Literature DB >> 8970376

Proteoglycan deposition in pulmonary fibrosis.

E S Bensadoun1, A K Burke, J C Hogg, C R Roberts.   

Abstract

This study compares the deposition of proteoglycans in the extracellular matrix of the lung lesions of the adult respiratory distress syndrome (ARDS) and bronchiolitis obliterans organizing pneumonia (BOOP) to those present in idiopathic pulmonary fibrosis (IPF). Tissue from individuals with ARDS (n = 7), BOOP (n = 5), IPF (n = 5), and control subjects (n = 5) was examined for glycosaminoglycans and collagen by histochemistry, and for hyaluronan, versican, decorin, biglycan, Types I and III collagen, type I procollagen and alpha-smooth muscle actin (alpha-SMA) using immunohistochemistry. The results showed that glycosaminoglycan deposition in the lesions of ARDS, BOOP, and IPF corresponded to the deposition of versican. Versican localized to the thickened interstitium in the fibroproliferative phase of ARDS, to the intraluminal buds in BOOP, and to early fibroblast foci in IPF. The versican-rich areas contained little mature collagen, but the myofibroblasts in these areas stained for type I procollagen, suggesting early collagen synthesis, and stained intracellularly for decorin. The localization of versican in ARDS, BOOP, and IPF suggests that this proteoglycan may influence early repair processes in the lung.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970376     DOI: 10.1164/ajrccm.154.6.8970376

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  62 in total

Review 1.  What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine.

Authors:  A Scott; K M Khan; C R Roberts; J L Cook; V Duronio
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

Review 2.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 4.  Emerging Therapies for Spastic Movement Disorders.

Authors:  Preeti Raghavan
Journal:  Phys Med Rehabil Clin N Am       Date:  2018-06-02       Impact factor: 1.784

Review 5.  Lung extracellular matrix and fibroblast function.

Authors:  Eric S White
Journal:  Ann Am Thorac Soc       Date:  2015-03

6.  Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.

Authors:  Jeremy Herrera; Colleen Forster; Thomas Pengo; Angeles Montero; Joe Swift; Martin A Schwartz; Craig A Henke; Peter B Bitterman
Journal:  JCI Insight       Date:  2019-01-10

7.  Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide.

Authors:  Yoshinori Tanino; Mary Y Chang; Xintao Wang; Sean E Gill; Shawn Skerrett; John K McGuire; Suguru Sato; Takefumi Nikaido; Tetsuhito Kojima; Mitsuru Munakata; Steve Mongovin; William C Parks; Thomas R Martin; Thomas N Wight; Charles W Frevert
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-15       Impact factor: 6.914

8.  Versican: a novel modulator of hepatic fibrosis.

Authors:  Terence N Bukong; Sean B Maurice; Barinder Chahal; David F Schaeffer; Paul J Winwood
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

9.  Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.

Authors:  Jessica M Snyder; Ida M Washington; Timothy Birkland; Mary Y Chang; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

10.  Multiwalled Carbon Nanotube Functionalization with High Molecular Weight Hyaluronan Significantly Reduces Pulmonary Injury.

Authors:  Salik Hussain; Zhaoxia Ji; Alexia J Taylor; Laura M DeGraff; Margaret George; Charles J Tucker; Chong Hyun Chang; Ruibin Li; James C Bonner; Stavros Garantziotis
Journal:  ACS Nano       Date:  2016-08-02       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.